Skip to main content
Watch Insiders
CLPTHealthcare

ClearPoint Neuro Inc (CLPT) Insider Trading

In the last 90 days, no ClearPoint Neuro Inc (CLPT) insiders reported open-market purchases or sales on SEC Form 4.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 29, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 29, 2026Joseph BurnettCEO and PresidentSale20,000$19.38$387,600
Jun 17, 2026Joseph BurnettCEO and PresidentSale61,843$17.79$1,100,465
Jun 1, 2026Timothy T. RichardsDirectorSale5,415$12.17$65,901
May 21, 2026Matthew B. KleinDirectorSale16,000$11.59$185,440
May 20, 2026Lynnette C FallonDirectorSale5,091$11.14$56,714

Common questions

CLPT insider trading FAQ

Are CLPT insiders buying or selling?
No CLPT insiders reported open-market purchases or sales in the last 90 days.
When was the last CLPT insider purchase?
No open-market insider purchase of ClearPoint Neuro Inc stock was reported in the last 90 days.
Where does CLPT insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that ClearPoint Neuro Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.